Evidence map›Paper›PMID 38066492›Full record

ArticleBMC health services research2023

Feasibility and acceptability of the use of flash glucose monitoring encountered by Indigenous Australians with type 2 diabetes mellitus: initial experiences from a pilot study.

Audrey Sing Yi Eer, Rebecca Chia Yee Ho, Tracey Hearn, Mariam Hachem, Megan Freund, Luke James Burchill, Sharon Atkinson-Briggs, Satpal Singh, Sandra Eades, Richard Charles O'Brien and 11 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC health services research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Continuous glucose monitoring in type 2 diabetes: a systematic review of barriers and opportunities for care improvement.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2025
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 11 institutions in 2 countries.

Audrey Sing Yi EerAustin Health, Heidelberg, VIC, Australia.
Rebecca Chia Yee HoAlbany Health Campus, Spencer Park, WA, Australia.
Tracey HearnThe University of Melbourne, Melbourne, VIC, Australia.
Mariam HachemThe University of Melbourne (Austin Health), Melbourne, VIC, Australia.
Megan FreundResearch Academic, School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.
Luke James BurchillRoyal Melbourne Hospital, Parkville, VIC, Australia.
Sharon Atkinson-BriggsRumbalara Aboriginal Co-Operative, Mooroopna, VIC, Australia.
Satpal SinghRumbalara Aboriginal Co-Operative, Mooroopna, VIC, Australia.
Sandra EadesFaculty of Medicine Dentistry and Health Sciences, The University of Melbourne, Melbourne, VIC, Australia.
Richard Charles O'BrienAustin Clinical School, The University of Melbourne, Melbourne, VIC, Australia.
John Stuart FurlerDepartment of General Practice, Faculty of Medicine Dentisty and Health Sciences, The University of Melbourne, Melbourne, VIC, Australia.
David Norman O'NealThe Australian Centre for Accelerating Diabetes Innovation (ACADI), The University of Melbourne, Parkville, Australia.
David Andrew StoryAustin Health, Heidelberg, VIC, Australia.
Jeffrey David ZajacThe University of Melbourne (Austin Health), Melbourne, VIC, Australia.
Sabine BraatCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
Alex BrownIndigenous Genomics, Australian National University and Telethon Kids Institute, Canberra, Australian Capital Territory, Australia.
Phillip ClarkeThe Australian Centre for Accelerating Diabetes Innovation (ACADI), The University of Melbourne, Parkville, Australia.
Ashim Kumar SinhaDiabetes and Endocrinology, Cairns Hospital, Cairns, QLD, Australia.
Anna Gerardina McLeanEndocrinology and General Medicine, Cairns Hospital, Cairns, QLD, Australia.
Stephen Morris TwiggThe Australian Centre for Accelerating Diabetes Innovation (ACADI), The University of Melbourne, Parkville, Australia.
Elif Ilhan EkinciAustin Health, Heidelberg, VIC, Australia. elif.ekinci@unimelb.edu.au.
University of Melbourne · AUAustin Health · AUTharawal Aboriginal · AUAustralian National University · AUJames Cook University · AUMenzies School of Health Research · AURoyal Prince Alfred Hospital · AUSt Vincent's Hospital · AUThe Royal Melbourne Hospital · AUUniversity of Newcastle Australia · AUVictorian Curriculum and Assessment Authority · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundType 2 diabetes mellitus (T2DM) is highly prevalent within the Indigenous Australian community. Novel glucose monitoring technology offers an accurate approach to glycaemic management, providing real-time information on glucose levels and trends. The acceptability and feasibilility of this technology in Indigenous Australians with T2DM has not been investigated.

objectiveThis feasibility phenomenological study aims to understand the experiences of Indigenous Australians with T2DM using flash glucose monitoring (FGM).

methodsIndigenous Australians with T2DM receiving injectable therapy (n = 8) who used FGM (Abbott Freestyle Libre) for 6-months, as part of a clinical trial, participated in semi-structured interviews. Thematic analysis of the interviews was performed using NVivo12 Plus qualitative data analysis software (QSR International).

resultsSix major themes emerged: 1) FGM was highly acceptable to the individual; 2) FGM's convenience was its biggest benefit; 3) data from FGM was a tool to modify lifestyle choices; 4) FGM needed to be complemented with health professional support; 5) FGM can be a tool to engage communities in diabetes management; and 6) cost of the device is a barrier to future use.

conclusionsIndigenous Australians with T2DM had positive experiences with FGM. This study highlights future steps to ensure likelihood of FGM is acceptable and effective within the wider Indigenous Australian community.

Indexed as

Blood Glucose Self-MonitoringDiabetes Mellitus, Type 2AustraliaAustralian Aboriginal and Torres Strait Islander PeoplesBlood GlucoseFeasibility StudiesHumansPilot ProjectsBlood GlucoseAboriginal peopleFlash glucose monitoringIndigenous AustralianPhenomenological studyQualitative researchType 2 diabetes mellitus

Identifiers

PMID38066492
PMCPMC10704698
OpenAlexW4389485299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.